Cargando…
Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
An online survey was conducted to compare the safety, tolerability and reactogenicity of available COVID-19 vaccines in different recipient groups. This survey was launched in February 2021 and ran for 11 days. Recipients of a first COVID-19 vaccine dose ≥7 days prior to survey completion were eligi...
Autores principales: | Mathioudakis, Alexander G., Ghrew, Murad, Ustianowski, Andrew, Ahmad, Shazaad, Borrow, Ray, Papavasileiou, Lida Pieretta, Petrakis, Dimitrios, Bakerly, Nawar Diar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002738/ https://www.ncbi.nlm.nih.gov/pubmed/33803014 http://dx.doi.org/10.3390/life11030249 |
Ejemplares similares
-
Obtaining real-world evidence: the Salford Lung Study
por: New, John P, et al.
Publicado: (2014) -
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma
por: Woodcock, Ashley, et al.
Publicado: (2015) -
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease
por: Bakerly, Nawar Diar, et al.
Publicado: (2015) -
The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019) -
Safety data in randomised real-world evidence studies: Salford Lung Study learnings
por: Harvey, Catherine, et al.
Publicado: (2021)